IP Verse

Lipid Nanoparticle Compositions And Methods For Mrna Delivery

Patent No. EP4458350 (titled "Lipid Nanoparticle Compositions And Methods For Mrna Delivery") was filed by Translate BIO on Jun 8, 2012. The application was issued on Dec 24, 2025.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (7)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GLAXOSMITHKLINE BIOLOGICALS SASep 24, 2026WILLEMS
MAIWALD PATENTANWALTSSep 24, 2026MAIWALD PATENT- UND RECHTSANWALTSGESELLSCHAFT MBH
MARGARET DIXONSep 24, 2026MEWBURN ELLIS
MERCK SHARP & DOHMESep 24, 2026J A KEMP
STRAWMANSep 24, 2026MAIWALD PATENT- UND RECHTSANWALTSGESELLSCHAFT MBH
WACHTERSHAUSER & HARTZ PATENTANWALTSPARTNERSCHAFT MBB BLODIGSep 24, 2026WACHTERSHAUSER & HARTZ PATENTANWALTSPARTNERSCHAFT MBB
PFIZERSep 23, 2026PFIZER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP4458350

TRANSLATE BIO
Application Number
EP24197314A
Filing Date
Jun 8, 2012
Status
Granted And Under Opposition
Nov 21, 2025
Publication Date
Dec 24, 2025
External Links
Slate, Register , Google Patents